DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactSector

Nifty Pharma Today: Index Performance, Stocks & Analysis

Univest 3 hrs ago·20 Aug 2026, 10:43 am

Excerpt from Univest

Updated: 20 Aug 2026 • 4:14 pm Nifty Pharma today ended in positive territory, but the session was far from one-sided. The index stood at 26,416, up 102.2 points or 0.39% versus the previous close of 26,313.8. That headline gain shows resilience in the pharmaceutical pack, yet the underlying picture was mixed because…

Read the original at Univest